Home › Scleroderma › New York › New York City
Pag-aaral pangklinika para sa Scleroderma sa New York City, NY
Isang pag-aaral para sa Scleroderma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New York City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Nagre-recruitPhase 3
- Hospital for Special Surgery, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Nagre-recruitPhase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Nagre-recruitPhase 2/3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Platform Clinical Study for Conquering Scleroderma
Nagre-recruitPhase 2
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Nagre-recruitPhase 2/3
- Columbia University Irving Medical Center, New York
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Nagre-recruitPhase 1/2
- Nkarta Investigational Site, New York
A Study of AZD0120 in Autoimmune Diseases
Nagre-recruitPhase 1
- Research Site, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Nagre-recruitPhase 1
- Montefiore Medical Center, New York
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Nagre-recruitPhase 2
- Hospital for Special Surgery, New York
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Nagre-recruitPhase 2
- aTyr Investigative Site, New York
Pag-aaral para sa Scleroderma sa ibang lungsod
- Ann Arbor, MI10 pag-aaral
- Chicago, IL10 pag-aaral
- Houston, TX9 pag-aaral
- Boston, MA7 pag-aaral
- Durham, NC7 pag-aaral
- Los Angeles, CA7 pag-aaral
- New Orleans, LA6 pag-aaral
- Philadelphia, PA6 pag-aaral
- Baltimore, MD6 pag-aaral
- Dallas, TX5 pag-aaral
- Pittsburgh, PA5 pag-aaral
- Plantation, FL4 pag-aaral
Iba pang pag-aaral sa New York City
- Kanser sa Suso134 pag-aaral
- Non-Small Cell Lung Cancer120 pag-aaral
- Kanser (lahat ng uri)110 pag-aaral
- Kanser sa Prostate103 pag-aaral
- Metastatic Cancer93 pag-aaral
- Colorectal Cancer77 pag-aaral
- Kanser sa Ovary69 pag-aaral
- Kanser sa Baga60 pag-aaral
- Kanser sa Pancreas60 pag-aaral
- Multiple Myeloma60 pag-aaral
- Kanser ng Endometrium52 pag-aaral
- Pagkabigo ng Puso51 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.